位置：成果数据库 > 期刊 > 期刊详情页
Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic pote
  • ISSN号：1932-6203
  • 期刊名称：PLos One
  • 时间：2013
  • 页码：e78901-e78901
  • 相关项目：揭示微环境中趋化因子Decoy受体的功能性基因多态对乳腺癌转移潜能的影响
作者： Yang, Chen|Yu, Ke-Da|Xu, Wen-Huan|Chen, Ao-Xiang|Fan, Lei|Ou, Zhou-Luo|Shao, Zhi-Ming|
同期刊论文项目
揭示微环境中趋化因子Decoy受体的功能性基因多态对乳腺癌转移潜能的影响
期刊论文 21
同项目期刊论文
Immediate postmastectomy breast reconstruction showed limited advantage in patient survival after st
Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survi
Weekly paclitaxel/carboplatin/trastuzumab therapy improves pathologic complete remission in aggressi
Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breas
Effect of large tumor size on cancer-specific mortality in node-negative breast cancer.
Initiation, evolution, phenotype and outcome of BRCA1 and BRCA2 mutation-associated breast cancer.
Genetic variants in oxidative stress-related genes predict chemoresistance in primary breast cancer:
ESR1 gene amplification: another mechanism regulating the cellular levels of ERalpha.
Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast canc
Different annual recurrence pattern between lumpectomy and mastectomy: implication for breast cancer
The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer ris
Inspection of a deviation from Hardy-Weinberg equilibrium in familial breast cancer cases from a cas
The two faces of autophagy and the pathological underestimation of DCIS.
Is RAD51 135G>C polymorphism really associated with breast cancer in general population? Biased d
Hazard of breast cancer-specific mortality among women with estrogen receptor-positive breast cancer
Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS wit
Polymorphism rs4919510:C>G in mature sequence of human microRNA-608 contributes to the risk of HE
Gene variations associated with drug resistance in breast cancer